(Q41830928)

12 October 2017

Pharmacodynamic interaction between phenytoin and sodium valproate changes seizure thresholds and pattern (English)

1 reference

12 October 2017

1 reference

1 reference

1 reference

5

Danhof M

1 reference

12 October 2017

Della Paschoa OE

1

1 reference

12 October 2017

Kruk MR

series ordinal

2

1 reference

12 October 2017

Hamstra R

series ordinal

3

1 reference

12 October 2017

Voskuyl RA

series ordinal

4

1 reference

12 October 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

British Journal of Pharmacology

12 October 2017

1 reference

12 October 2017

125

1 reference

12 October 2017

5

1 reference

12 October 2017

997-1004

1 reference

The long-term therapeutic management of epilepsy

12 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

Pharmacokinetic-pharmacodynamic (PK-PD) modelling in non-steady-state studies and arterio-venous drug concentration differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

Pharmacokinetic Interaction of Zonisamide in Rats. Effect of Other Antiepileptics on Zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

Strategies for identifying and developing new anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

The new generation of antiepileptic drugs: advantages and disadvantages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

Animal models relevant to human epilepsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Antiepileptic drug combinations and experimental background: the case of phenobarbital and phenytoin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Drug interactions in epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Established antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Pharmacodynamic interactions between phenytoin and valproate: individual and combined antiepileptic and neurotoxic actions in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Seizure patterns in kindling and cortical stimulation models of experimental epilepsy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Gas chromatographic method for the measurement of sodium valproate utilization by kidney tubules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Progression and generalization of seizure discharge: anatomical and neurochemical substrates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Role of GABA in the genesis of chemoconvulsant seizures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Subcortical structures and pathways involved in convulsive seizure generation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Kinetics of drug action in disease states. XXI. Relationship between drug infusion rate and dose required to produce a pharmacologic effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Short- and long-term alterations of gene expression in limbic structures by repeated electroconvulsive-induced seizures.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: phenytoin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Intravenous infusion anaesthesia and delivery devices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Application of a variable direction hysteresis minimization approach in describing the central nervous system pharmacodynamic effects of alfentanil in rabbits.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Pharmacokinetic drug interactions with phenytoin (Part I).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Pharmacokinetic interactions with antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

A timed intravenous pentylenetetrazol infusion seizure model for quantitating the anticonvulsant effect of valproic acid in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Modification of seizure activity by electrical stimulation. I. After-discharge threshold.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Drug treatment of epilepsy in the 1990s. Achievements and new developments.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Repeated generalized seizures induce time-dependent changes in the behavioral seizure response independent of continued seizure induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Inhibition or enhancement of kindling evolution by antiepileptics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Laboratory evaluation of antiepileptic drugs. Review of laboratory methods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Properties of maximal seizures, and their alteration by anticonvulant drugs and other agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Developmental seizure models.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Determination of the threshold for convulsions by direct cortical stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Properties of the convulsive threshold determined by direct cortical stimulation in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702155

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0702155

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

9846637

1 reference